IRBS — IR BioSciences Holdings Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for IR BioSciences Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2006 December 31st | 2007 December 31st | 2008 December 31st | 2009 December 31st | 2010 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB | 10KSB | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.49 | -5.46 | -5.81 | -6.46 | -5.28 |
| Depreciation | |||||
| Non-Cash Items | -0.524 | 2.49 | 0.976 | 3.5 | 2.96 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.034 | 0.503 | 0.044 | 0.076 | 1.88 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -2.04 | -2.46 | -4.77 | -2.88 | -0.43 |
| Capital Expenditures | -0.032 | -0.025 | -0.02 | -0.002 | 0 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.032 | -0.025 | -0.02 | -0.002 | 0 |
| Financing Cash Flow Items | 0 | 0 | 0 | 0 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.55 | -0.05 | 7.73 | 0 | 0.15 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.49 | -2.53 | 2.94 | -2.88 | -0.28 |